Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known ...

A highly sensitive test that detects traces of disease in the bone marrow of patients with a rare and aggressive type of blood cancer could help double their chances of survival, a first-of-its-kind ...

Patients with a rare and aggressive type of blood cancer could soon have their chances of survival doubled as a groundbreaking trial to detect the disease earlier concludes. Scientists working on the ...

Diagnosis typically involves a physical exam to check for swollen lymph nodes and blood tests to measure lymphocyte counts. In some cases, bone marrow tests are used to evaluate cancer progression. CT ...

What if a blood test could reveal the pace of our aging—and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at the Weizmann Institute of Science have been conducting in ...

Chronic lymphocytic leukemia (CLL) is a form of cancer that leads to an atypically high level of lymphocytes within the bone marrow. Tests, such as a bone marrow biopsy, can determine how advanced CLL ...

Blood tests may be the first step in diagnosing leukemia. However, additional testing is usually needed to make an accurate diagnosis. Leukemia is cancer that starts in bone marrow stem cells. These ...

Doctors use multiple diagnostic tests, including blood, bone marrow, and genetic assessments, to diagnose chronic lymphocytic leukemia. Following testing, doctors categorize CLL into five stages.

Paroxysmal nocturnal hemoglobinuria (PNH) affects your bone marrow, where your body makes new blood cells. It can be hard to diagnose. For one thing, it's rare. And its symptoms look like those of ...